Business Wire

HYPREVENTION Raised € 750,000 to Finance the Y-STRUT® Product Launch, a Unique Medical Device to Prevent Hip Fracture.

Del

After obtaining the CE marking for the medical device Y-STRUT ® in August 2015, HYPREVENTION recorded its first sales in France and signed its first distribution agreement in Belgium. To continue its business development in Europe and in many emerging countries. HYPREVENTION raised € 750,000 end of 2015. Investors comprised Expanso CAPITAL, a subsidiary of the Caisse d'Epargne Aquitaine Poitou Charente, as well as the Be Angels, Business Angels Switzerland and Cercle des Investisseurs de Genève.

About Y-STRUT ® :
The implant Y-STRUT®, developed by HYPREVENTION, aims at preserving the autonomy and quality of life of the patients who are at risk of hip fracture. Hip fracture is a major public health problem which frequently causes dependency and associated expenses.
Y-STRUT® is used in two clinical indications. In trauma, for the biomechanical reinforcement of the proximal femur in patients having incurred a low energy trochanteric fracture on the other side, and in oncology, for percutaneous internal reinforcement of impending pathological fractures of the proximal femur.

About HYPREVENTION:
HYPREVENTION was created in 2010 by Cécile Vienney (CEO) and 3 orthopaedic surgeons. HYPREVENTION is a French company that develops, manufactures and markets innovative implantable medical devices to address major public health issues. HYPREVENTION was supported in its early development by the French public actors such as BPI France and the Regional Council of Aquitaine.
Thanks to the recent fund raising, HYPREVENTION can now further develop its sales team and implement the opportunities it identified in Europe, South America and the Middle East. HYPREVENTION can now not only pursue its scientific agenda through clinical trials focused on patient’s benefit, but also the planned health economy studies necessary to support the hip fracture prevention approach as a goal to avoid health costs.

About Expanso CAPITAL:
Expanso CAPITAL is the capital investment subsidiary close to the Caisse d'Epargne Aquitaine Poitou-Charentes, dedicated exclusively to assist corporate clients of the bank, regardless of their activities and their maturity stage, and this with "tickets " of € 50,000 to € 300,000.

About the Caisse d'Epargne Aquitaine Poitou Charentes:
Caisse d'Epargne Aquitaine Poitou Charente is a cooperative regional bank owned by its 334,300 member clients with which it shares its democratic values, territorial roots and solidarity. Covering the 9 departments of Aquitaine and Poitou-Charentes regions, CEAPC enjoys optimum territorial coverage with 3 administrative sites, 10 business centres, sales offices and 376 e-agency’s. Its 2800 employees are serving 2 million customers, individuals, professionals, companies and regional market makers. A committed bank, CEAPC is developing an ambitious CSR policy based on strong convictions and relevant actions around the following themes: customer relationships, human resources, environment, governance, regional social and economic life.

About Be Angels:
Be Angels is the active business angel network in the Walloon Region and the Brussels-Capital Region. With 15 years of experience, the network organizes a monthly event in which four companies seeking financing, usually in start-up phase, present their project to its member investors. Business angels are willing not only to invest, but also to support project promoters in accordance with their needs. Be Angels allows its members to invest according to their wealth, time availability, and investment objectives.

About BAS :
BAS (Business Angels Switzerland), the largest business angels club in the country, showed interest for Hyprevention from the outset. BAS supports start-up companies through capital financing, expertise sharing and know-how, as well as personal contacts and access to its network; it is with this mind-set that its support forHyprevention materialised. BAS members invest their own time and money, and financed more than 80 enterprises within the framework of the club.

Contact information

HYPREVENTION:
Cecile Vienney, +33 (0)5 57 10 28 52
contact@hyprevention.com
or
Expanso CAPITAL:
Jean-Luc Minet
jean-luc.minet@ceapc.caisse-epargne.fr
or
Be Angels:
Claire Munck
clmunck@beangels.be
or
BAS :
Caroline Gueissaz
Caroline.Gueissaz@businessangels.ch

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Nearly 1 Billion People Worldwide Have Sleep Apnea, International Sleep Experts Estimate21.5.2018 18:15Pressemelding

A new data analysis presented by ResMed (NYSE: RMD, ASX: RMD) this week at the ATS 2018 International Conference indicates that the prevalence of sleep apnea impacts more than 936 million people worldwide – nearly 10 times greater than previous estimates. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005096/en/ Woman wearing CPAP, the gold standard treatment for sleep apnea (Photo: Business Wire) The study “Global Prevalence of Obstructive Sleep Apnea (OSA)” was conducted by an international panel of leading researchers seeking to provide a clear scope of the impact of the chronic sleep-disordered breathing condition. The previous estimation of OSA prevalence (100 million) came from a 2007 World Health Organization study that used methods and data available at the time. By analyzing technology improvements in detecting OSA and underreported statistics from other areas of the world, this latest study depicts an impacte

Pietro Rosa TBM Signs Long-Term Agreement with Pratt & Whitney21.5.2018 15:13Pressemelding

Pietro Rosa TBM (Turbine Blade Manufacturing) today announced that it has signed a 10-year, long-term agreement (LTA) with Pratt & Whitney, a division of United Technologies Corp., to supply airfoil products for both commercial and military engines. The LTA, which may extend to the entire Pietro Rosa TBM Group in Europe and the United States, will support Pratt & Whitney’s F135, PW2000 and the Geared Turbofan™ (GTF) family of engines. This agreement represents a significant step in the collaboration between the two companies, enabling the Pietro Rosa TBM Group to utilize its advanced engineering capabilities and the vertical integration of hot forming, machining and surface finishing technologies. “We’re pleased to sign this agreement with Pietro Rosa,” said Art Erikson, executive director of Strategic Sourcing, Pratt & Whitney. “We have tremendous growth ahead, and suppliers like Pietro Rosa that sign up to our contractual governance, commitment to cost competitiveness and continuous

NioCorp Awards Contract to Rockwell Automation on Groundbreaking Critical Minerals, Mining and Processing Facility in Nebraska21.5.2018 12:00Pressemelding

NioCorp Developments Ltd. (TSX: NB, OTCQX: NIOBF), a developer of superalloy metals, has awarded a major contract to Rockwell Automation (NYSE: ROK) to engineer, design and procure process automation and instrumentation for NioCorp’s proposed critical minerals, mining and processing facility in Elk Creek, Nebraska. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005228/en/ Three superalloy metals – niobium, scandium and titanium – are expected to be produced by the facility as early as 2021. These critical materials are used in the aerospace, defense, automotive, clean energy, commercial aviation and mega-infrastructure sectors. Generally, these superalloys enable increased strength and lighter weight in transportation and other systems, leading to better fuel efficiency and lower greenhouse gas and other air emissions, according to NioCorp. “We selected Rockwell Automation and its partners to automate our process equip

Ultra-Low Power Lattice sensAI Leads Mass Market Enablement of Artificial Intelligence in Edge Devices21.5.2018 12:00Pressemelding

Lattice Semiconductor Corporation (NASDAQ: LSCC) today unveiled Lattice sensAI™ – a complete technology stack combining modular hardware kits, neural network IP cores, software tools, reference designs and custom design services – to accelerate integration of machine learning inferencing into broad market IoT applications. With solutions optimized for ultra-low power consumption (under 1 mW–1 W), small package size (5.5 mm2 –100 mm2), interface flexibility (MIPI® CSI-2, LVDS, GigE, etc.), and high-volume pricing (~$1-$10 USD), Lattice sensAI stack fast-tracks implementation of edge computing close to the source of data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005011/en/ (Graphic: Business Wire) “Lattice sensAI addresses the unmet need for flexible, low cost, ultra-low power AI silicon solutions suited for rapid deployment across a wide range of emerging, mass market IoT applications,” said Deepak Boppana, senior

Biosimilars could facilitate early access to life changing biological treatments for patients says Celltrion Healthcare21.5.2018 11:27Pressemelding

At the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 23rd Annual International Meeting in Baltimore, Celltrion Healthcare today advocated for healthcare systems to introduce biologics earlier in a patient’s treatment regimen in order to improve clinical outcomes. Several studies show that the early introduction of biologics can bring greater clinical benefit to patients.1,2,3,4,5,6 However, only a limited number of patients have access to biological treatment due to the high-cost of biologics and current reimbursement policies determined by pharmacoeconomic evaluations. Since the introduction of biosimilars, the overall cost of biological treatments has reduced in Europe, allowing an increased number of patients to access this important treatment option earlier in their course of treatment.7 Professor Jørgen Jahnsen said, “For the treatment of inflammatory bowel disease, biological treatments are proven to be the most efficacious medical therapy and their ea

Dole’s Joint Venture Recycling Company Celebrates 25 Years21.5.2018 11:00Pressemelding

Dole Food Company announced today that Recyplast S.A., an innovative plastic recycling company based in Costa Rica and with joint ownership including a subsidiary of Dole Fresh Fruit, recently surpassed 25 years in its mission to dramatically reduce and reuse agricultural waste. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005160/en/ Raul Martinez (right), General Manager of Dole Standard Fruit de Costa Rica, receives a plaque from Jose Miguel Ramirez, General Manager of Recyplast, in recognition of the contribution of Dole's banana plantations in the correct handling, storage, and provision of field plastic waste. The plastic recycling facility pioneered the collection of field plastics after use in banana growing operations in Costa Rica. This reuse and recycling process includes reclamation of plastic bags that protect bananas from weather and insects, as well as the collection of plastic twine used to prop the ba